ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[
Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesHouge type of X-linked syndromic intellectual developmental disorder (MRXSHG) caused by
methodsA retrospective analysis was conducted on the clinical data of 7 children diagnosed with
resultsThe reported age ranged from 4 months to 62 years, with a male-to-female ratio of 11.2꞉1. Major clinical manifestations included global developmental delay/intellectual disability (100%, 49/49), epilepsy (91.8%, 45/49), attention deficit hyperactivity disorder (77.6%, 38/49), absence of speech (75.5%, 37/49), and sleep disturbances (28.6%, 14/49). Among 36 patients with available sleep electroencephalogram data, 16 (44.4%) exhibited ESES. A minority of patients also presented with feeding difficulties (12.2%, 6/49), autism spectrum disorder (10.2%, 5/49), abnormal muscle tone (6.1%, 3/49), microcephaly (6.1%, 3/49), and facial dysmorphism (4.1%, 2/49). Four patients from our center exhibited short stature and/or malnutrition, which have not been previously reported. Among 34 patients with known epilepsy outcomes, 14 (41.2%) achieved seizure control with valproate, carbamazepine, or lamotrigine; 16 (47.1%) had refractory epilepsy; and 4 (11.8%) were untreated, had unclear seizure status, or were still undergoing treatment adjustment.
conclusionsFor male patients presenting with intellectual disability and prominent language delay, particularly those with refractory epilepsy and ESES, MRXSHG caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.